Serum Biomarkers in Parkinson's Disease at Different Stages

Institute of Hospitalization and Scientific Care (IRCCS)

Status: Enrolling

Conditions: Parkinson Disease

Treatments: Procedure: blood sample

Study type: Interventional

Funder types: Other

Identifiers

NCT05769699

4687

Details and patient eligibility

About

• Determine clinical characteristics of parkinsonian patients in various stages of disease;
• Measure peripheral neurodegeneration, synaptic, and inflammation biomarkers in a population of parkinsonian patients at various stages of disease.
• Measure vesicular neurodegeneration, synaptic and inflammation biomarkers

Enrollment: 200 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Patients diagnosed with idiopathic PD according to Movement Disorders Society (MDS) criteria;
• Age: 18-80 years;
• Signature of informed consent to participate in this study

Exclusion criteria.

• Women pregnant
• Inflammatory or autoimmune diseases

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

200 participants in 1 patient group

Biomarkers

Experimental group

Treatment:

Procedure: blood sample